| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.055 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |